|
|
| (2 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| − | {{bibi|TI=Mg - QTc|S1=%22mg2%2B%22+OR+magnesium+OR+mgso4+OR+hypomagnes*+OR+hypermagnes*+OR+trpm7|S2=chloroquine+OR+hydroxychloroquine|S3=|dPMID=08/05/20|dPMC=08/05/20}}
| |
| − | {{tp|p=22174173|t=2011. A rare electrocardiographic manifestation of a rare form of multiple electrolyte disturbances: hyperparathyroid crisis.|pdf=|usr=}}
| |
| − | {{tp|p=8209703|t=1994. Hepatite aguda alcoolica complicada com arritmia cardiaca. Alcool, hepatite, hipomagnesiemia, torsade de pointes, corticoterapia.|pdf=|usr=}}
| |
| − | {{tp|p=1539780|t=1992. Torsade de pointes and long QT syndrome following major blood transfusion.|pdf=|usr=}}
| |
| − | {{tp|p=24303973|t=2013. Licorice-induced severe hypokalemia with recurrent torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=32389016|t=2020. Torsade de pointes in initiating hemodialysis: a case report.|pdf=|usr=}}
| |
| − | {{tp|p=14666271|t=2003. Female alcoholics: electrocardiographic changes and associated metabolic and electrolytic disorders.|pdf=|usr=}}
| |
| − | {{tp|p=23060109|t=2012. Serum levels of magnesium in sudden cardiac deaths among people with schizophrenia: hit or miss?|pdf=|usr=}}
| |
| − | {{tp|p=21452253|t=2011. Prolonged corrected QT interval in anti-Ro/SSA-positive adults with systemic lupus erythematosus.|pdf=|usr=}}
| |
| − | {{tp|p=25815024|t=2014. Methadone induced torsades de pointes and ventricular fibrillation: A case review.|pdf=|usr=}}
| |
| − | {{tp|p=22947859|t=2012. Multi-ion distributions in the cytoplasmic domain of inward rectifier potassium channels.|pdf=|usr=}}
| |
| − | {{tp|p=20712994|t=2010. Phosphatidylinositol-4,5-bisphosphate (PIP(2)) stabilizes the open pore conformation of the Kv11.1 (hERG) channel.|pdf=|usr=}}
| |
| − | {{tp|p=11566776|t=2001. Unitary conductance variation in Kir2.1 and in cardiac inward rectifier potassium channels.|pdf=|usr=}}
| |
| − | {{tp|p=9788926|t=1998. Interaction of Ba2+ with the pores of the cloned inward rectifier K+ channels Kir2.1 expressed in Xenopus oocytes.|pdf=|usr=}}
| |
| − | {{tp|p=8842207|t=1996. [K+] dependence of open-channel conductance in cloned inward rectifier potassium channels (IRK1, Kir2.1).|pdf=|usr=}}
| |
| − | {{tp|p=31783793|t=2019. Prevalence and risk factors of prolonged corrected QT interval in general Chinese population.|pdf=|usr=}}
| |
| − | {{tp|p=30157775|t=2018. Effect of serum electrolytes within normal ranges on QTc prolongation: a cross-sectional study in a Chinese rural general population.|pdf=|usr=}}
| |
| − | {{tp|p=30999887|t=2019. Associations of serum and dialysate electrolytes with QT interval and prolongation in incident hemodialysis: the Predictors of Arrhythmic and Cardiovascular Risk in End-Stage Renal Disease (PACE) study.|pdf=|usr=}}
| |
| − | {{tp|p=27797880|t=2016. Ventricular fibrillation via torsade des pointes of cardiac sarcoidosis with preserved left ventricular ejection fraction.|pdf=|usr=}}
| |
| − | {{tp|p=24121811|t=2013. Overdrive pacing in a patient with incessant torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=22987900|t=2012. Severe primary hypothyroidism presenting with torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=23203174|t=2012. Syncope in a patient being treated for hepatic and intestinal amoebiasis.|pdf=|usr=}}
| |
| − | {{tp|p=32169926|t=2020. Drug use and torsades de pointes cardiac arrhythmias in Sweden: a nationwide register-based cohort study.|pdf=|usr=}}
| |
| − | {{tp|p=2467681|t=1989. Electrocardiographic findings and frequency of arrhythmias in Bartter's syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=26183037|t=2016. Pharmacological treatment of acquired QT prolongation and torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=19812810|t=2009. A sweet tooth as the root cause of cardiac arrest.|pdf=|usr=}}
| |
| − | {{tp|p=27212965|t=2016. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management.|pdf=|usr=}}
| |
| − | {{tp|p=29304463|t=2018. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs.|pdf=|usr=}}
| |
| − | {{tp|p=22825908|t=2012. QT interval prolongation and torsades de pointes in a patient undergoing treatment with vorinostat: a case report and review of the literature.|pdf=|usr=}}
| |
| − | {{tp|p=21660912|t=2011. Electrolyte disorders and arrhythmogenesis.|pdf=|usr=}}
| |
| − | {{tp|p=28357022|t=2012. Failure to Treat Torsades de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=24428853|t=2014. Antibiotic-induced cardiac arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=18690045|t=2007. Differences between ion binding to eag and HERG voltage sensors contribute to differential regulation of activation and deactivation gating.|pdf=|usr=}}
| |
| − | {{tp|p=32554946|t=2020. Magnesium Deficiency Causes Transcriptional Downregulation of Kir2.1 and Kv4.2 Channels in Cardiomyocytes Resulting in QT Interval Prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=10526691|t=1999. Prolongation of the QT interval in children with liver failure.|pdf=|usr=}}
| |
| − | {{tp|p=9068917|t=1997. A practical approach to torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=7902224|t=1993. Torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=8269653|t=1993. Magnesium and the heart: antiarrhythmic therapy with magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=8416758|t=1993. Abnormal QT intervals associated with negative T waves induced by antiarrhythmic drugs are rapidly reduced using magnesium sulfate as an antidote.|pdf=|usr=}}
| |
| − | {{tp|p=1551265|t=1992. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia.|pdf=|usr=}}
| |
| − | {{tp|p=1660796|t=1991. Acute effects of the ACE inhibitor lisinopril on cardiac electrophysiological parameters of isolated guinea pig hearts.|pdf=|usr=}}
| |
| − | {{tp|p=26251626|t=2015. Serum magnesium concentrations in patients receiving sodium picosulfate and magnesium citrate bowel preparation: an assessment of renal function and electrocardiographic conduction.|pdf=|usr=}}
| |
| − | {{tp|p=26069818|t=2012. Magnesium in disease.|pdf=|usr=}}
| |
| − | {{tp|p=29849428|t=2017. Methadone-induced Torsades de Pointes Masquerading as Seizures.|pdf=|usr=}}
| |
| − | {{tp|p=32670733|t=2020. Magnesium Supplementation Shortens Hemodialysis-Associated Prolonged QT.|pdf=|usr=}}
| |
| − | {{tp|p=22114630|t=2011. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=12101132|t=2002. The role of magnesium in the emergency department.|pdf=|usr=}}
| |
| − | {{tp|p=31911979|t=2019. Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report.|pdf=|usr=}}
| |
| − | {{tp|p=24940425|t=2014. Increasing gap junction coupling suppresses ibutilide-induced torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=29731714|t=2018. Proton Pump Inhibitors and Serum Magnesium Levels in Patients With Torsades de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=30270992|t=2018. Effect of Hemodialysis on Corrected QT Interval and QTc Dispersion.|pdf=|usr=}}
| |
| − | {{tp|p=22529489|t=2012. Phenytoin in treatment of amiodarone-induced Torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=19646241|t=2009. Prolonged QT interval in a man with anorexia nervosa.|pdf=|usr=}}
| |
| − | {{tp|p=30305584|t=2018. Persistent QT Prolongation in a Child with Gitelman Syndrome and SCN5A H558R Polymorphism.|pdf=|usr=}}
| |
| − | {{tp|p=20720356|t=2010. Premature atrial contraction induces torsades de pointes in a patient of Takotsubo cardiomyopathy with QT prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=9372331|t=1997. Torsades de pointes complicating pentamidine therapy of Pneumocystis carinii pneumonia in acute myelogenous leukemia.|pdf=|usr=}}
| |
| − | {{tp|p=19377216|t=2008. Improvement of maximum corrected QT and corrected QT dispersion in electrocardiography after kidney transplantation.|pdf=|usr=}}
| |
| − | {{tp|p=28471572|t=2016. Magnesium-Responsive Polymorphic Ventricular Tachycardia Associated with Alcoholic Binge Drinking.|pdf=|usr=}}
| |
| − | {{tp|p=31221261|t=2019. Effects of Calcium, Magnesium, and Potassium Concentrations on Ventricular Repolarization in Unselected Individuals.|pdf=|usr=}}
| |
| − | {{tp|p=11583899|t=2001. Pause-dependent torsade de pointes following acute myocardial infarction: a variant of the acquired long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=2661626|t=1989. Electrophysiologic substrate of torsade de pointes: dispersion of repolarization or early afterdepolarizations?|pdf=|usr=}}
| |
| − | {{tp|p=3711493|t=1986. Effects of magnesium sulfate on cardiac conduction and refractoriness in humans.|pdf=|usr=}}
| |
| − | {{tp|p=6630761|t=1983. Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.|pdf=|usr=}}
| |
| − | {{tp|p=26802105|t=2016. Serum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac Death.|pdf=|usr=}}
| |
| − | {{tp|p=10361868|t=1999. QT dispersion in patients with end-stage renal failure and during hemodialysis.|pdf=|usr=}}
| |
| − | {{tp|p=10405219|t=1999. Hypomagnesemia.|pdf=|usr=}}
| |
| − | {{tp|p=29021858|t=2017. Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia.|pdf=|usr=}}
| |
| − | {{tp|p=19944332|t=2009. Torsades de Pointes with QT prolongation related to donepezil use.|pdf=|usr=}}
| |
| − | {{tp|p=24653589|t=2013. Torsade de pointes as a reperfusion arrhythmia following intravenous thrombolytic therapy.|pdf=|usr=}}
| |
| − | {{tp|p=22394705|t=2012. Pseudohypoparathyroidism presenting with ventricular arrhythmia: a case report.|pdf=|usr=}}
| |
| − | {{tp|p=16533896|t=2006. Functional roles of charged amino acid residues on the wall of the cytoplasmic pore of Kir2.1.|pdf=|usr=}}
| |
| − | {{tp|p=12407079|t=2002. Ser165 in the second transmembrane region of the Kir2.1 channel determines its susceptibility to blockade by intracellular Mg2+.|pdf=|usr=}}
| |
| − | {{tp|p=9382895|t=1997. A conserved arginine residue in the pore region of an inward rectifier K channel (IRK1) as an external barrier for cationic blockers.|pdf=|usr=}}
| |
| − | {{tp|p=8740374|t=1996. Fast inactivation causes rectification of the IKr channel.|pdf=|usr=}}
| |
| − | {{tp|p=10205594|t=1999. Life-threatening ventricular tachycardia due to liquorice-induced hypokalaemia.|pdf=|usr=}}
| |
| − | {{tp|p=11410700|t=2001. A case of torsade de pointes associated with hypopituitarism due to hemorrhagic fever with renal syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=18821491|t=2008. Cardiotoxicity after massive amantadine overdose.|pdf=|usr=}}
| |
| − | {{tp|p=18570170|t=2008. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.|pdf=|usr=}}
| |
| − | {{tp|p=20015154|t=2010. Cholesterol modulates ion channels via down-regulation of phosphatidylinositol 4,5-bisphosphate.|pdf=|usr=}}
| |
| − | {{tp|p=15618275|t=2005. Two Kir2.1 channel populations with different sensitivities to Mg(2+) and polyamine block: a model for the cardiac strong inward rectifier K(+) channel.|pdf=|usr=}}
| |
| − | {{tp|p=12205194|t=2002. Cytosolic Ca2+ triggers early afterdepolarizations and Torsade de Pointes in rabbit hearts with type 2 long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=12411513|t=2002. Identification of a site involved in the block by extracellular Mg(2+) and Ba(2+) as well as permeation of K(+) in the Kir2.1 K(+) channel.|pdf=|usr=}}
| |
| − | {{tp|p=10066894|t=1999. Kir2.1 encodes the inward rectifier potassium channel in rat arterial smooth muscle cells.|pdf=|usr=}}
| |
| − | {{tp|p=9508824|t=1998. Voltage-dependent blockade of HERG channels expressed in Xenopus oocytes by external Ca2+ and Mg2+.|pdf=|usr=}}
| |
| − | {{tp|p=7884731|t=1994. Torsades de pointes-like polymorphic ventricular tachycardia in a dog.|pdf=|usr=}}
| |
| − | {{tp|p=29759319|t=2015. Mexiletine Prevents Recurrent Torsades de Pointes in Acquired Long QT Syndrome Refractory to Conventional Measures.|pdf=|usr=}}
| |
| − | {{tp|p=10875735|t=2000. Effect of magnesium sulfate on the haloperidol-induced QT prolongation assessed in the canine in vivo model under the monitoring of monophasic action potential.|pdf=|usr=}}
| |
| − | {{tp|p=12110021|t=2002. Electrocardiogram with prolonged QT interval in Gitelman disease.|pdf=|usr=}}
| |
| − | {{tp|p=30596175|t=2019. Clinical and Genetic Characteristics in Patients With Gitelman Syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=23755081|t=2013. Acquired Long QT Syndrome Manifesting with Torsades de Pointes in a Patient with Panhypopituitarism due to Radiotherapy.|pdf=|usr=}}
| |
| − | {{tp|p=25558343|t=2014. Ventricular arrhythmia in patients with prolonged QT interval during liver transplantation: two cases report.|pdf=|usr=}}
| |
| − | {{tp|p=24578711|t=2014. Channelopathies.|pdf=|usr=}}
| |
| − | {{tp|p=21977140|t=2010. Polymorphic ventricular tachycardia in acute myocardial infarction treated by thrombolysis: reperfusion, complication or iatrogenic sign?|pdf=|usr=}}
| |
| − | {{tp|p=25967879|t=2015. The relationship between repolarization parameters and serum electrolyte levels in patients with J wave syndromes.|pdf=|usr=}}
| |
| − | {{tp|p=26878253|t=2015. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.|pdf=|usr=}}
| |
| − | {{tp|p=20353903|t=2010. Magnesium and cardiovascular system.|pdf=|usr=}}
| |
| − | {{tp|p=30558036|t=2018. Aldosteronism with mild hypokalemia presenting as life-threatening ventricular arrhythmias: A case report.|pdf=|usr=}}
| |
| − | {{tp|p=29245320|t=2017. QTc prolongation and torsades de pointes due to a coadministration of fluoxetine and amiodarone in a patient with implantable cardioverter-defibrillator: Case report and review of the literature.|pdf=|usr=}}
| |
| − | {{tp|p=30169383|t=2019. Critical Consideration of Myxedema Coma in the Postoperative Setting: A Case Report.|pdf=|usr=}}
| |
| − | {{tp|p=25470888|t=2014. A comparison of the effects of lidocaine or magnesium sulfate on hemodynamic response and QT dispersion related with intubation in patients with hypertension.|pdf=|usr=}}
| |
| − | {{tp|p=24397608|t=2014. Drug-induced long QT syndrome and fatal arrhythmias in the intensive care unit.|pdf=|usr=}}
| |
| − | {{tp|p=11942876|t=2002. Perioperative management of long QT syndrome in a child with congenital heart disease.|pdf=|usr=}}
| |
| − | {{tp|p=20128168|t=2009. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=30220246|t=2019. Hypomagnesemia and hypermagnesemia.|pdf=|usr=}}
| |
| − | {{tp|p=24697004|t=2013. A case of recurrent arrhythmia in an acute pancreatitis patient--pathophysiological explanation using shortage of 'repolarization reserve'.|pdf=|usr=}}
| |
| − | {{tp|p=3993440|t=1985. The relationship between QTc changes and nutrition during weight loss after gastroplasty.|pdf=|usr=}}
| |
| − | {{tp|p=10830458|t=2000. Heart risk associated with weight loss in anorexia nervosa and eating disorders: electrocardiographic changes during the early phase of refeeding.|pdf=|usr=}}
| |
| − | {{tp|p=16156840|t=2005. Torsade de pointes in a patient with complex medical and psychiatric conditions receiving low-dose quetiapine.|pdf=|usr=}}
| |
| − | {{tp|p=12534434|t=2003. The importance of the QT interval: a review of the literature.|pdf=|usr=}}
| |
| − | {{tp|p=7572567|t=1995. Torsades de pointes and long QT syndromes.|pdf=|usr=}}
| |
| − | {{tp|p=17540188|t=2007. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=14597941|t=2003. Evaluation of the dofetilide risk-management program.|pdf=|usr=}}
| |
| − | {{tp|p=11773906|t=2002. Long QT syndrome: diagnosis and management.|pdf=|usr=}}
| |
| − | {{tp|p=2729056|t=1989. Effect of the infusion of magnesium sulfate during atrial pacing on ECG intervals, serum electrolytes, and blood pressure.|pdf=|usr=}}
| |
| − | {{tp|p=49775|t=1975. Letter: Glycerol in cerebral oedema.|pdf=|usr=}}
| |
| | | | |
| − | {{tp|p=31942276|t=2020. Mirtazapine's effect on the QT interval in medically hospitalized patients.|pdf=|usr=}}
| |
| − | {{tp|p=22470374|t=2011. QT Interval and QT Dispersion in Patients Undergoing Hemodialysis: Revisiting the Old Theory.|pdf=|usr=}}
| |
| − | {{tp|p=27471598|t=2016. Hypomagnesemia as a potentially life-threatening adverse effect of omeprazole.|pdf=|usr=}}
| |
| − | {{tp|p=24155819|t=2012. Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation.|pdf=|usr=}}
| |
| − | {{tp|p=25350118|t=2014. Lack of negatively charged residues at the external mouth of Kir2.2 channels enable the voltage-dependent block by external Mg2+.|pdf=|usr=}}
| |
| − | {{tp|p=24681627|t=2014. A long QT mutation substitutes cholesterol for phosphatidylinositol-4,5-bisphosphate in KCNQ1 channel regulation.|pdf=|usr=}}
| |
| − | {{tp|p=12151568|t=2002. Changes in the corrected QT interval and corrected QT dispersion during haemodialysis.|pdf=|usr=}}
| |
| − | {{tp|p=1409197|t=1992. Sotalol-induced torsade de pointes: management with magnesium infusion.|pdf=|usr=}}
| |
| − | {{tp|p=3341171|t=1988. Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac disease.|pdf=|usr=}}
| |
| − | {{tp|p=3766386|t=1986. Efficacy of magnesium sulfate in the treatment of torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=3966318|t=1985. Torsade de pointes and magnesium deficiency.|pdf=|usr=}}
| |
| − | {{tp|p=20723644|t=2010. Effect of high doses of magnesium on converting ibutilide to a safe and more effective agent.|pdf=|usr=}}
| |
| − | {{tp|p=12767447|t=2003. Prenatal diagnosis and in utero treatment of torsades de pointes associated with congenital long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=12586278|t=2003. Effect of short- and long-duration spaceflight on QTc intervals in healthy astronauts.|pdf=|usr=}}
| |
| − | {{tp|p=9354415|t=1997. Proarrhythmia with class III antiarrhythmic drugs: types, risks, and management.|pdf=|usr=}}
| |
| − | {{tp|p=2296905|t=1990. Magnesium sulfate is the treatment for torsades de pointes if the right dose is given.|pdf=|usr=}}
| |
| − | {{tp|p=2729150|t=1989. Treatment of torsade de pointes with intravenous magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=2650516|t=1989. Magnesium treatment of ventricular arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=6695782|t=1984. Magnesium therapy for torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=6650429|t=1983. Hypomagnesemic torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=14728075|t=2003. Does magnesium have a role in the treatment of patients with coronary artery disease?|pdf=|usr=}}
| |
| − | {{tp|p=8358483|t=1993. The importance of magnesium in cardiovascular disease.|pdf=|usr=}}
| |
| − | {{tp|p=27914889|t=2017. Ventricular tachycardia and prolonged QT interval presenting as seizure-like activity.|pdf=|usr=}}
| |
| − | {{tp|p=24462399|t=2014. The use of isoproterenol and phenytoin to reverse torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=23896010|t=2013. Citalopram and levosulpiride: a dangerous drug combination for QT prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=21075581|t=2012. Isoproterenol as an adjunct for treatment of idiopathic ventricular fibrillation storm in a pregnant woman.|pdf=|usr=}}
| |
| − | {{tp|p=20006210|t=2010. Termination of drug-induced torsades de pointes with overdrive pacing.|pdf=|usr=}}
| |
| − | {{tp|p=19857426|t=2009. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning.|pdf=|usr=}}
| |
| − | {{tp|p=9928709|t=1999. Torsades de pointes: a case with multiple variables.|pdf=|usr=}}
| |
| − | {{tp|p=7945604|t=1994. Torsades de pointes induced by erythromycin and terfenadine.|pdf=|usr=}}
| |
| − | {{tp|p=2914039|t=1989. Magnesium sulfate termination of torsades de pointes following failure of cardioversion.|pdf=|usr=}}
| |
| − | {{tp|p=7733096|t=1995. Torsade de pointes complicating the treatment of bleeding esophageal varices: association with neuroleptics, vasopressin, and electrolyte imbalance.|pdf=|usr=}}
| |
| − | {{tp|p=18359968|t=2008. Torsades de pointes in a patient receiving fluconazole for cerebral cryptococcosis.|pdf=|usr=}}
| |
| − | {{tp|p=15119574|t=2004. Model of effect of magnesium prophylaxis on frequency of torsades de pointes in ibutilide-treated patients.|pdf=|usr=}}
| |
| − | {{tp|p=8438899|t=1993. Induction of hypomagnesemia during Amsacrine treatment.|pdf=|usr=}}
| |
| − | {{tp|p=25864370|t=2015. Magnesium and Dialysis: The Neglected Cation.|pdf=|usr=}}
| |
| − | {{tp|p=25828570|t=2015. Dialysate and serum potassium in hemodialysis.|pdf=|usr=}}
| |
| − | {{tp|p=12500237|t=2003. Cell-associated magnesium and QT dispersion in hemodialysis patients.|pdf=|usr=}}
| |
| − | {{tp|p=27639872|t=2017. Association of Serum Magnesium on Mortality in Patients Admitted to the Intensive Cardiac Care Unit.|pdf=|usr=}}
| |
| − | {{tp|p=11812408|t=2002. Clinical and therapeutic aspects of congenital and acquired long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=3499072|t=1987. Torsade de pointes during administration of pentamidine isethionate.|pdf=|usr=}}
| |
| − | {{tp|p=3565423|t=1987. Effects of low potassium or magnesium concentrations on isolated cardiac tissue.|pdf=|usr=}}
| |
| − | {{tp|p=20610973|t=2010. A dyshomeostasis of electrolytes and trace elements in acute stressor states: impact on the heart.|pdf=|usr=}}
| |
| − | {{tp|p=7771501|t=1995. Case report: reversible QT prolongation with torsades de pointes in a patient with pimozide intoxication.|pdf=|usr=}}
| |
| − | {{tp|p=8475949|t=1993. Case report: pentamidine and polymorphic ventricular tachycardia revisited.|pdf=|usr=}}
| |
| − | {{tp|p=12832258|t=2003. Side effects of ziprasidone.|pdf=|usr=}}
| |
| − | {{tp|p=14704599|t=2004. Ciprofloxacin- and hypocalcemia-induced torsade de pointes triggered by hemodialysis.|pdf=|usr=}}
| |
| − | {{tp|p=12845389|t=2003. Ibutilide for pharmacological cardioversion of atrial fibrillation and flutter: impact of race on efficacy and safety.|pdf=|usr=}}
| |
| − | {{tp|p=11304665|t=2001. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography.|pdf=|usr=}}
| |
| − | {{tp|p=11197564|t=2001. Prevalence and prognostic importance of hypomagnesemia and hypocalcemia in horses that have colic surgery.|pdf=|usr=}}
| |
| − | {{tp|p=21364460|t=2011. Magnesium--essentials for anesthesiologists.|pdf=|usr=}}
| |
| − | {{tp|p=2301766|t=1990. The effect of magnesium sulfate administration on cerebral and cardiac toxicity of bupivacaine in dogs.|pdf=|usr=}}
| |
| − | {{tp|p=12678199|t=2003. Amiodarone-induced torsade de pointes during bladder irrigation: an unusual presentation--a case report.|pdf=|usr=}}
| |
| − | {{tp|p=10870859|t=2000. Increased QT interval dispersion after hemodialysis: role of peridialytic electrolyte gradients.|pdf=|usr=}}
| |
| − | {{tp|p=2389840|t=1990. Magnesium treatment of torsade de pointes--a case report.|pdf=|usr=}}
| |
| − | {{tp|p=2629617|t=1989. Proprietes electrophysiologiques cliniques du magnesium et correlations avec son efficacite anti-arythmique dans les torsades de pointe acquises.|pdf=|usr=}}
| |
| − | {{tp|p=8599503|t=1996. Magnesium sulfate for conversion of supraventricular tachycardia refractory to intravenous adenosine.|pdf=|usr=}}
| |
| − | {{tp|p=2817575|t=1989. Magnesium sulfate & torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=3304038|t=1987. Torsades de pointes: atypical rhythm, atypical treatment.|pdf=|usr=}}
| |
| − | {{tp|p=8572407|t=1995. Indications du magnesium en anesthesie-reanimation.|pdf=|usr=}}
| |
| − | {{tp|p=1363741|t=1992. Effets arythmogenes du chlorydrate de sultopride: correlation clinique et electrophysiologique cellulaire.|pdf=|usr=}}
| |
| − | {{tp|p=2418718|t=1985. Torsades de pointe et hypomagnesemie.|pdf=|usr=}}
| |
| − | {{tp|p=7469224|t=1981. Torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=3152846|t=1988. Il solfato di magnesio nella terapia della tachicardia ventricolare a torsione di punta.|pdf=|usr=}}
| |
| − | {{tp|p=24285766|t=2013. Azithromycin-induced proarrhythmia and cardiovascular death.|pdf=|usr=}}
| |
| − | {{tp|p=23362038|t=2013. Torsades de pointes after administration of low-dose aripiprazole.|pdf=|usr=}}
| |
| − | {{tp|p=10534216|t=1999. Haloperidol-induced torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=1477438|t=1992. Prolonged recurrence of pentamidine-induced torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=7786143|t=1995. Mecanisme d'action des antiarythmiques de classe III.|pdf=|usr=}}
| |
| − | {{tp|p=8267505|t=1993. Les torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=1550438|t=1992. Effets du magnesium sur les post-depolarisations precoces et l'activite declenchee induites par le cesium sur les fibres de Purkinje de furet.|pdf=|usr=}}
| |
| − | {{tp|p=3122681|t=1987. Effets electrophysiologiques du sulfate de magnesium intraveineux chez l'homme.|pdf=|usr=}}
| |
| − | {{tp|p=3087320|t=1986. Effets anti-arythmiques du sulfate de magnesium intraveineux dans les torsades de pointes. A propos de 6 observations.|pdf=|usr=}}
| |
| − | {{tp|p=3096233|t=1986. Traitement des torsades de pointes par magnesium intraveineux.|pdf=|usr=}}
| |
| − | {{tp|p=28766238|t=2017. Magnesium isoglycyrrhizinate inhibits L-type Ca(2+) channels, Ca(2+) transients, and contractility but not hERG K(+) channels.|pdf=|usr=}}
| |
| − | {{tp|p=14692159|t=2003. Torsades de pointes following cardioversion: case history and literature review.|pdf=|usr=}}
| |
| − | {{tp|p=2196873|t=1990. Proarrhythmic actions of antiarrhythmic drugs: a review.|pdf=|usr=}}
| |
| − | {{tp|p=9782371|t=1998. Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts.|pdf=|usr=}}
| |
| − | {{tp|p=19653656|t=2009. Ion-blocking sites of the Kir2.1 channel revealed by multiscale modeling.|pdf=|usr=}}
| |
| − | {{tp|p=22057978|t=2012. Inhibition of sodium current by taurine magnesium coordination compound prevents cesium chloride-induced arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=19655100|t=2010. Clinical effects of cesium intake.|pdf=|usr=}}
| |
| − | {{tp|p=10958097|t=2000. Management of prolonged QT interval during a massive transfusion: calcium, magnesium or both?|pdf=|usr=}}
| |
| − | {{tp|p=8595691|t=1995. Diuretic-induced hypokalaemia inducing torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=9627533|t=1998. Torsade de pointes with sotalol overdose treated successfully with lidocaine.|pdf=|usr=}}
| |
| − | {{tp|p=19935903|t=2009. Inhibitory effects of dauricine on early afterdepolarizations and L-type calcium current.|pdf=|usr=}}
| |
| − | {{tp|p=11007539|t=2000. Block of inwardly rectifying K+ currents by extracellular Mg2+ and Ba2+ in bovine pulmonary artery endothelial cells.|pdf=|usr=}}
| |
| − | {{tp|p=20544619|t=2010. Multifactorial QT interval prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=14766022|t=2004. Vitamins, supplements, herbal medicines, and arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=10348955|t=1998. Acquired QT Prolongation: Mechanisms and Implications.|pdf=|usr=}}
| |
| − | {{tp|p=2085823|t=1990. Magnesium and cardiac arrhythmias. Reappraisal of an old substance.|pdf=|usr=}}
| |
| − | {{tp|p=12652102|t=2002. The influence of magnesium on the electrophysiological effects of erythromycin in the isolated Guinea pig heart.|pdf=|usr=}}
| |
| − | {{tp|p=1854660|t=1991. Torsades de pointes: prevention and therapy.|pdf=|usr=}}
| |
| − | {{tp|p=1854659|t=1991. Terminology of torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=9231028|t=1997. Role of interventricular dispersion of repolarization in acquired torsade-de-pointes arrhythmias: reversal by magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=9302346|t=1997. Magnesium abolishes inadequate kinetics of frequency adaptation of the Q-aT interval in the presence of sotalol.|pdf=|usr=}}
| |
| − | {{tp|p=8001044|t=1994. Triggered activity and automaticity in ventricular trabeculae of failing human and rabbit hearts.|pdf=|usr=}}
| |
| − | {{tp|p=3256422|t=1988. Pharmacological response of quinidine induced early afterdepolarisations in canine cardiac Purkinje fibres: insights into underlying ionic mechanisms.|pdf=|usr=}}
| |
| − | {{tp|p=29873021|t=2018. The Effects of Lipid Emulsion, Magnesium Sulphate and Metoprolol in Amitriptyline-Induced Cardiovascular Toxicity in Rats.|pdf=|usr=}}
| |
| − | {{tp|p=25253561|t=2015. Analysis of an ECG record database reveals QT interval prolongation potential of famotidine in a large Korean population.|pdf=|usr=}}
| |
| − | {{tp|p=18690034|t=2007. Exaggerated Mg2+ inhibition of Kir2.1 as a consequence of reduced PIP2 sensitivity in Andersen syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=19433077|t=2009. Modulation of haloperidol induced electrophysiological alterations on cardiac action potential by various risk factors and gender difference.|pdf=|usr=}}
| |
| − | {{tp|p=8131528|t=1994. Magnesium sulfate potentiates several cardiovascular and metabolic actions of terbutaline.|pdf=|usr=}}
| |
| − | {{tp|p=15746441|t=2005. Impaired KCNQ1-KCNE1 and phosphatidylinositol-4,5-bisphosphate interaction underlies the long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=9598592|t=1998. Dynamic Ca2+-induced inward rectification of K+ current during the ventricular action potential.|pdf=|usr=}}
| |
| − | {{tp|p=9168780|t=1997. Rapid inactivation determines the rectification and [K+]o dependence of the rapid component of the delayed rectifier K+ current in cardiac cells.|pdf=|usr=}}
| |
| − | {{tp|p=7828315|t=1995. Reproducible induction of early afterdepolarizations and torsade de pointes arrhythmias by d-sotalol and pacing in dogs with chronic atrioventricular block.|pdf=|usr=}}
| |
| − | {{tp|p=1914096|t=1991. Polymorphous ventricular tachycardia associated with acute myocardial infarction.|pdf=|usr=}}
| |
| − | {{tp|p=2917391|t=1989. Quinidine-induced action potential prolongation, early afterdepolarizations, and triggered activity in canine Purkinje fibers. Effects of stimulation rate, potassium, and magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=3370776|t=1988. Magnesium suppression of early afterdepolarizations and ventricular tachyarrhythmias induced by cesium in dogs.|pdf=|usr=}}
| |
| − | {{tp|p=3338130|t=1988. Treatment of torsade de pointes with magnesium sulfate.|pdf=|usr=}}
| |
| − | {{tp|p=22846359|t=2012. [Magnesium metabolism and therapeutic strategy in cardiovascular disease].|pdf=|usr=}}
| |
| − | {{tp|p=15692161|t=2005. [Heart rate variability, arrhythmia and magnesium in hemodialysis patients].|pdf=|usr=}}
| |
| − | {{tp|p=11453949|t=2001. Hyperthyroidism is associated with lengthening of ventricular repolarization.|pdf=|usr=}}
| |
| − | {{tp|p=16698131|t=2006. Tolerable infusion rate of citrate based on clinical signs and the electrocardiogram in conscious dogs.|pdf=|usr=}}
| |
| − | {{tp|p=2416504|t=1985. Drug-induced torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=15001976|t=2004. Torsades de pointes associated with fluoroquinolones: importance of concomitant risk factors.|pdf=|usr=}}
| |
| − | {{tp|p=2974361|t=1988. Il problema della tachicardia ventricolare a torsione di punta e della sua razionale terapia.|pdf=|usr=}}
| |
| − | {{tp|p=27022002|t=2016. Not your regular high: cardiac dysrhythmias caused by loperamide.|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=20671821|t=2010. Causes and management of drug-induced long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=22299661|t=2012. The effect of different dialysate magnesium concentrations on QTc dispersion in hemodialysis patients.|pdf=|usr=}}
| |
| − | {{tp|p=26869275|t=2016. A synergistic blocking effect of Mg(2)(+) and spermine on the inward rectifier K(+) (Kir2.1) channel pore.|pdf=|usr=}}
| |
| − | {{tp|p=25630313|t=2014. Importance of QT interval in clinical practice.|pdf=|usr=}}
| |
| − | {{tp|p=31637554|t=2019. Temporary loss of consciousness during cetuximab treatment of a patient with metastatic colon cancer: a case report.|pdf=|usr=}}
| |
| − | {{tp|p=15616901|t=2004. Molecular and clinical determinants of drug-induced long QT syndrome: an iatrogenic channelopathy.|pdf=|usr=}}
| |
| − | {{tp|p=32603470|t=2020. Acquired Long QT Syndrome after Acute Myocardial Infarction: A Rare but Potentially Fatal Entity.|pdf=|usr=}}
| |
| − | {{tp|p=25057346|t=2014. Quetiapine, QTc interval prolongation, and torsade de pointes: a review of case reports.|pdf=|usr=}}
| |
| − | {{tp|p=19907690|t=2009. Drugs, electrolytes and tako-tsubo cardiomyopathy: triple aetiology of acquired long QT syndrome and torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=25706450|t=2015. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.|pdf=|usr=}}
| |
| − | {{tp|p=20199131|t=2010. A case of torsades de pointes induced by severe QT prolongation after an overdose of eperisone and triazolam in a patient receiving nifedipine.|pdf=|usr=}}
| |
| − | {{tp|p=18363122|t=2008. Non-fatal ventricular dysrhythmias associated with severe salicylate toxicity.|pdf=|usr=}}
| |
| − | {{tp|p=22668123|t=2012. Overdose of atypical antipsychotics: clinical presentation, mechanisms of toxicity and management.|pdf=|usr=}}
| |
| − | {{tp|p=21649448|t=2011. Assessing QT interval prolongation and its associated risks with antipsychotics.|pdf=|usr=}}
| |
| − | {{tp|p=2129926|t=1990. Torsades de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=17879860|t=2007. Prolonged QTc intervals on admission electrocardiograms: prevalence and correspondence with admission electrolyte abnormalities.|pdf=|usr=}}
| |
| − | {{tp|p=1989768|t=1991. Cardiac arrest secondary to emotional stress and torsade de pointes in a patient with associated magnesium and potassium deficiency.|pdf=|usr=}}
| |
| − | {{tp|p=3257726|t=1988. Torsade de pointes in a patient receiving intravenous vasopressin.|pdf=|usr=}}
| |
| − | {{tp|p=19281438|t=2009. The relationship between blood glucose level and QTc duration in the critically ill.|pdf=|usr=}}
| |
| − | {{tp|p=16573402|t=2002. Cardiac arrhythmias: diagnosis and management. The tachycardias.|pdf=|usr=}}
| |
| − | {{tp|p=12917054|t=2003. Advances in the acute pharmacologic management of cardiac arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=24020938|t=2013. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.|pdf=|usr=}}
| |
| − | {{tp|p=11096483|t=1999. Torsades de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=26249264|t=2015. QT interval prolongation associated with low magnesium in chronic alcoholics.|pdf=|usr=}}
| |
| − | {{tp|p=27241860|t=2017. The prevalence of QT prolongation in a population of patients with substance use disorders.|pdf=|usr=}}
| |
| − | {{tp|p=22702639|t=2012. Examination of baseline risk factors for QTc interval prolongation in patients prescribed intravenous haloperidol.|pdf=|usr=}}
| |
| − | {{tp|p=11994029|t=2002. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview.|pdf=|usr=}}
| |
| − | {{tp|p=7727055|t=1994. Drug-induced torsade de pointes. Incidence, management and prevention.|pdf=|usr=}}
| |
| − | {{tp|p=8129865|t=1993. Class III antiarrhythmics in overdose. Presenting features and management principles.|pdf=|usr=}}
| |
| − | {{tp|p=10553703|t=1999. Toxicity of quinolones.|pdf=|usr=}}
| |
| − | {{tp|p=7510621|t=1994. Torsade de pointes. Mechanisms and management.|pdf=|usr=}}
| |
| − | {{tp|p=20210367|t=2010. Safety considerations of fluoroquinolones in the elderly: an update.|pdf=|usr=}}
| |
| − | {{tp|p=12641485|t=2003. Fluoroquinolones in the elderly: safety considerations.|pdf=|usr=}}
| |
| − | {{tp|p=11740632|t=2001. QT-Verlangerung und Torsade de pointes-Tachykardie bei Therapie mit Maprotilin. Differenzialdiagnostische und -therapeutische Aspekte.|pdf=|usr=}}
| |
| − | {{tp|p=7588195|t=1995. Wide complex tachycardia.|pdf=|usr=}}
| |
| − | {{tp|p=11217540|t=2000. Antipsychotiques et securite cardio-vasculaire: donnees actuelles sur les allongements de l'intervalle QT et le risque d'arythmies ventriculaires.|pdf=|usr=}}
| |
| − | {{tp|p=10099907|t=1999. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction.|pdf=|usr=}}
| |
| − | {{tp|p=8293755|t=1993. Early after-depolarizations and torsade de pointes: implications for the control of cardiac arrhythmias by prolonging repolarization.|pdf=|usr=}}
| |
| − | {{tp|p=27154527|t=2019. Severe Torsades de Pointes with acquired QT prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=27634841|t=2017. Treating arrhythmias with adjunctive magnesium: identifying future research directions.|pdf=|usr=}}
| |
| − | {{tp|p=24817413|t=2014. Drug interactions and protease inhibitors used in the treatment of hepatitis C: how to manage?|pdf=|usr=}}
| |
| − | {{tp|p=10853872|t=2000. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience.|pdf=|usr=}}
| |
| − | {{tp|p=18304526|t=2008. Use and abuse of QT and TRIaD in cardiac safety research: importance of study design and conduct.|pdf=|usr=}}
| |
| − | {{tp|p=22389418|t=2012. In-hospital monitoring of T-wave alternans in a case of amiodarone-induced torsade de pointes: clinical and methodologic insights.|pdf=|usr=}}
| |
| − | {{tp|p=19351630|t=2009. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.|pdf=|usr=}}
| |
| − | {{tp|p=10362846|t=1999. Effect of extracellular cations on the inward rectifying K+ channels Kir2.1 and Kir3.1/Kir3.4.|pdf=|usr=}}
| |
| − | {{tp|p=23808631|t=2013. Hypomagnesemia and proton-pump inhibitors.|pdf=|usr=}}
| |
| − | {{tp|p=14585064|t=2003. Torsade de pointes associated with the administration of intravenous haloperidol:a review of the literature and practical guidelines for use.|pdf=|usr=}}
| |
| − | {{tp|p=31092056|t=2019. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=24147515|t=2013. Torsades de pointes following clarithromycin treatment.|pdf=|usr=}}
| |
| − | {{tp|p=14977544|t=2004. Magnesium in clinical medicine.|pdf=|usr=}}
| |
| − | {{tp|p=8458600|t=1993. Experimental models of torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=3436500|t=1987. I sali di magnesio nel trattamento della tachicardia ventricolare.|pdf=|usr=}}
| |
| − | {{tp|p=3556945|t=1986. Un caso di torsione di punta da ipomagnesiemia.|pdf=|usr=}}
| |
| − | {{tp|p=3556944|t=1986. "Torsione di punta" da antidepressivi triciclici. Descrizione di un caso clinico.|pdf=|usr=}}
| |
| − | {{tp|p=6532886|t=1984. Azione antiaritmica del solfato di magnesio nella aritmia ventricolare a "torsione di punta".|pdf=|usr=}}
| |
| − | {{tp|p=15750993|t=2004. Rischio aritmologico in pazienti emodializzati vs soggetti normali.|pdf=|usr=}}
| |
| − | {{tp|p=22847284|t=2012. Electrocardiographic, cardiac enzymes, and magnesium in patients with severe acute pancreatitis.|pdf=|usr=}}
| |
| − | {{tp|p=9888262|t=1999. Antiarrhythmic effects of magnesium on rat papillary muscle and guinea pig ventricular myocytes.|pdf=|usr=}}
| |
| − | {{tp|p=10461849|t=1999. Effects of nicardipine and bupivacaine on early after depolarization in rabbit sinoatrial node cells: a possible mechanism of bupivacaine-induced arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=21411146|t=2011. Methadone-induced torsades de pointes: a twist of fate.|pdf=|usr=}}
| |
| − | {{tp|p=9333595|t=1997. Medikamentose antiarrhythmische Therapie. Ist eine orale adjuvante Therapie mit Elektrolyten sinnvoll?|pdf=|usr=}}
| |
| − | {{tp|p=9333593|t=1997. Magnesiummangel und Magnesiumsubstitution. Einfluss auf ventrikulare Herzrhythmusstorungen unterschiedlicher Atiologie.|pdf=|usr=}}
| |
| − | {{tp|p=9333592|t=1997. Einfluss von Magnesium auf anhaltende ventrikulare Tachykardien.|pdf=|usr=}}
| |
| − | {{tp|p=9333591|t=1997. Klinisch-elektrophysiologische Effekte von Magnesium, insbesondere bei supraventrikularen Tachykardien.|pdf=|usr=}}
| |
| − | {{tp|p=32025785|t=2020. Long- und Short-QT-Syndrome : Notfalltherapie und Sekundarprophylaxe.|pdf=|usr=}}
| |
| − | {{tp|p=9821023|t=1998. Q-T interval prolongation and pleomorphic ventricular tachyarrhythmia ('Torsade de pointes') in organophosphate poisoning: report of a case.|pdf=|usr=}}
| |
| − | {{tp|p=15586745|t=2004. Seventy-four defibrillations for sotalol-induced torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=3229780|t=1988. Magnesium sulfate therapy in torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=16096514|t=2005. Antipsychotic drugs and QT prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=28100427|t=2017. The possible role of propofol in drug-induced torsades de pointes: A real-world single-center analysis.|pdf=|usr=}}
| |
| − | {{tp|p=19136164|t=2010. Pre-injection of magnesium sulfate enhances the efficacy of ibutilide for the conversion of typical but not of atypical persistent atrial flutter.|pdf=|usr=}}
| |
| − | {{tp|p=15301901|t=2004. Magnesium in treatment of acute myocardial infarction.|pdf=|usr=}}
| |
| − | {{tp|p=15159030|t=2004. Novel therapeutics for treatment of long-QT syndrome and torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=15193823|t=2004. Female preponderance in ibutilide-induced torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=11203051|t=2000. Torsades de pointes due to multihormonal deficiency induced long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=2365519|t=1990. Magnesium sulphate for torsade de pointes in a patient with congenital long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=3744606|t=1986. Limited effect of magnesium sulphate on torsades de pointes ventricular tachycardia.|pdf=|usr=}}
| |
| − | {{tp|p=28012118|t=2017. Risk factors for QTc-prolongation: systematic review of the evidence.|pdf=|usr=}}
| |
| − | {{tp|p=9744153|t=1998. Hypomagnesaemia in postoperative patients: an important contributing factor in postoperative mortality.|pdf=|usr=}}
| |
| − | {{tp|p=21496406|t=2011. The use of first generation versus second generation antipsychotics as add-on or as switch treatment and its effect on QTC interval: the Italian experience in a real-world setting.|pdf=|usr=}}
| |
| − | {{tp|p=27943168|t=2017. Hemodialysis-induced repolarization abnormalities on ECG are influenced by serum calcium levels and ultrafiltration volumes.|pdf=|usr=}}
| |
| − | {{tp|p=12122531|t=2002. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed.|pdf=|usr=}}
| |
| − | {{tp|p=14689085|t=2003. Tetanie.|pdf=|usr=}}
| |
| − | {{tp|p=11305536|t=2001. Amiodarone-induced torsade de pointes in a child with dilated cardiomyopathy.|pdf=|usr=}}
| |
| − | {{tp|p=11760927|t=2001. Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM).|pdf=|usr=}}
| |
| − | {{tp|p=17212573|t=2006. Acquired long QT syndrome secondary to cesium chloride supplement.|pdf=|usr=}}
| |
| − | {{tp|p=15466950|t=2004. Optimal administration dosage of magnesium sulfate for torsades de pointes in children with long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=3537078|t=1986. Magnesium and cardiac arrhythmias: nutrient or drug?|pdf=|usr=}}
| |
| − | {{tp|p=15278621|t=1991. Effects of lidocaine and verapamil on early afterdepolarizations in isolated rabbit sinoatrial node.|pdf=|usr=}}
| |
| − | {{tp|p=15270138|t=2004. Drug-induced long QT syndrome and Torsade de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=10999172|t=1999. Hypomagnesemia with hypokalemia in an uncontrolled diabetic patient presenting with recurrent episodes of torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=17987843|t=2007. [Despite medication, overdrive pacing is required to stabilize the electrical storm associated with acute coronary syndrome: a case report].|pdf=|usr=}}
| |
| − | {{tp|p=9253694|t=1997. [Pheochromocytoma of the left retroperitoneal paraganglion associated with torsade de pointes: a case report].|pdf=|usr=}}
| |
| − | {{tp|p=26706796|t=2015. Sudden Cardiac Death and Disorders of the QT Interval: Anesthetic Implications and Focus on Perioperative Management.|pdf=|usr=}}
| |
| − | {{tp|p=12108503|t=2002. Beta-adrenergic stimulation of pig myocytes with decreased cytosolic free magnesium prolongs the action potential and enhances triggered activity.|pdf=|usr=}}
| |
| − | {{tp|p=10355707|t=1999. Macroscopic T wave alternans as a harbinger of sudden death.|pdf=|usr=}}
| |
| − | {{tp|p=9300294|t=1997. Tissue magnesium levels and the arrhythmic substrate in humans.|pdf=|usr=}}
| |
| − | {{tp|p=9363818|t=1997. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.|pdf=|usr=}}
| |
| − | {{tp|p=8269292|t=1993. Drug therapy for torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=22990234|t=2013. Beat-to-beat corrected QT analysis detects corrected QT prolongation in 50 consecutive telemetry-monitored patients.|pdf=|usr=}}
| |
| − | {{tp|p=17031266|t=2006. Role of autonomic nervous activity in the antiarrhythmic effects of magnesium sulfate in a canine model of polymorphic ventricular tachyarrhythmia associated with prolonged QT interval.|pdf=|usr=}}
| |
| − | {{tp|p=10028924|t=1999. Modulation of HERG potassium channels by extracellular magnesium and quinidine.|pdf=|usr=}}
| |
| − | {{tp|p=10445681|t=1999. Female gender is a risk factor for torsades de pointes in an in vitro animal model.|pdf=|usr=}}
| |
| − | {{tp|p=9733356|t=1998. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.|pdf=|usr=}}
| |
| − | {{tp|p=7475058|t=1995. Electrophysiological and arrhythmogenic effects of the histamine type 1-receptor antagonist astemizole on rabbit Purkinje fibers: clinical relevance.|pdf=|usr=}}
| |
| − | {{tp|p=7532749|t=1994. Effects of magnesium on polymorphic ventricular tachycardias induced by aconitine.|pdf=|usr=}}
| |
| − | {{tp|p=1697384|t=1990. QTU-prolongation and torsades de pointes induced by putative class III antiarrhythmic agents in the rabbit: etiology and interventions.|pdf=|usr=}}
| |
| − | {{tp|p=1691383|t=1990. Pharmacologic response of cesium-induced ventricular tachyarrhythmias in anesthetized dogs.|pdf=|usr=}}
| |
| − | {{tp|p=10684450|t=1997. Antiarrhythmic and Arrhythmogenic Actions of Varying Levels of Extracellular Magnesium: Possible Cellular Basis for the Differences in the Efficacy of magnesium and Lidocaine in Torsade de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=24633623|t=2014. Gating of the kir2.1 channel at the bundle crossing region by intracellular spermine and other cations.|pdf=|usr=}}
| |
| − | {{tp|p=27543914|t=2017. QTc prolongation during peripheral stem cell apheresis in healthy volunteers.|pdf=|usr=}}
| |
| − | {{tp|p=31116446|t=2019. Loperamide: A Readily Available but Dangerous Opioid Substitute.|pdf=|usr=}}
| |
| − | {{tp|p=7665716|t=1995. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.|pdf=|usr=}}
| |
| − | {{tp|p=1753009|t=1991. Electrophysiologic mechanisms for ventricular arrhythmias in left ventricular dysfunction: electrolytes, catecholamines and drugs.|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=12823094|t=2003. Oral magnesium ion shortens prolonged QTc interval.|pdf=|usr=}}
| |
| − | {{tp|p=27492745|t=2017. A multidisciplinary approach to prenatal treatment of congenital long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=20832817|t=2010. Torsades: adjacent and triggering electrocardiographic events.|pdf=|usr=}}
| |
| − | {{tp|p=9005884|t=1997. Torsade de pointes as a complication of subarachnoid hemorrhage: a critical reappraisal.|pdf=|usr=}}
| |
| − | {{tp|p=1735792|t=1992. Effect of strontium on action potential repolarization in rabbit sinoatrial node cells.|pdf=|usr=}}
| |
| − | {{tp|p=28755998|t=2017. Loperamide-Induced Torsades de Pointes: A Case Series.|pdf=|usr=}}
| |
| − | {{tp|p=28007361|t=2017. A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.|pdf=|usr=}}
| |
| − | {{tp|p=17976767|t=2008. Management of ventricular dysrhythmia secondary to trazodone overdose.|pdf=|usr=}}
| |
| − | {{tp|p=18022786|t=2008. Chronic methadone therapy complicated by torsades de pointes: a case report.|pdf=|usr=}}
| |
| − | {{tp|p=1491157|t=1992. Magnesium: clinical considerations.|pdf=|usr=}}
| |
| − | {{tp|p=9071844|t=1997. Combined use of astemizole and ketoconazole resulting in torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=11519837|t=2001. Alcoholic liver cirrhosis complicated with torsade de pointes during plasma exchange and hemodiafiltration.|pdf=|usr=}}
| |
| − | {{tp|p=11253252|t=2000. The electrocardiographic QT interval and its prolongation in response to medications: differences between men and women.|pdf=|usr=}}
| |
| − | {{tp|p=18846329|t=2008. Effects of potassium aspartate and magnesium on ventricular arrhythmia in ischemia-reperfusion rabbit heart.|pdf=|usr=}}
| |
| − | {{tp|p=8523384|t=1995. Two new culprits in cardiovascular disease: QT dispersion and aldosterone.|pdf=|usr=}}
| |
| − | {{tp|p=14508199|t=2003. Dynamic QT interval analysis in uraemic patients receiving chronic haemodialysis.|pdf=|usr=}}
| |
| − | {{tp|p=1316396|t=1992. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death.|pdf=|usr=}}
| |
| − | {{tp|p=15665255|t=2005. Magnesium deficiency in critical illness.|pdf=|usr=}}
| |
| − | {{tp|p=25073261|t=2013. Treatment of methadone-induced torsades de pointes with lidocaine.|pdf=|usr=}}
| |
| − | {{tp|p=19303883|t=2009. Role of Mg(2+) block of the inward rectifier K(+) current in cardiac repolarization reserve: A quantitative simulation.|pdf=|usr=}}
| |
| − | {{tp|p=17582433|t=2007. T75M-KCNJ2 mutation causing Andersen-Tawil syndrome enhances inward rectification by changing Mg2+ sensitivity.|pdf=|usr=}}
| |
| − | {{tp|p=11829056|t=2002. Actions of Androctonus australis and Leiurus quinquestriatus venoms in the rat isolated atria and anesthetized rats; effect of magnesium and lidocaine.|pdf=|usr=}}
| |
| − | {{tp|p=19967647|t=2009. Vascular calcification and QT interval in incident hemodialysis patients.|pdf=|usr=}}
| |
| − | {{tp|p=15211156|t=2004. Traumatic subarachnoid hemorrhage and QTc prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=12755529|t=2003. Woman with postpartum ventricular tachycardia and hypomagnesemia.|pdf=|usr=}}
| |
| − | {{tp|p=24353019|t=2013. Prolonged QT interval by methadone: relevance for daily practice? A prospective study in patients with cancer and noncancer pain.|pdf=|usr=}}
| |
| − | {{tp|p=12354276|t=2002. Organophosphate poisoning complicated by a tachyarrhythmia and acute respiratory distress syndrome in a child.|pdf=|usr=}}
| |
| − | {{tp|p=9580612|t=1998. Gender difference in the cycle length-dependent QT and potassium currents in rabbits.|pdf=|usr=}}
| |
| − | {{tp|p=8355214|t=1993. Droperidol exerts dual effects on repolarization and induces early afterdepolarizations and triggered activity in rabbit Purkinje fibers.|pdf=|usr=}}
| |
| − | {{tp|p=15358992|t=2004. Magnesium homeostasis and antipsychotic-induced QTc prolongation.|pdf=|usr=}}
| |
| − | {{tp|p=14513929|t=2003. Antipsychotic induced prolongation of QTc interval treated with magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=21677914|t=2011. Monomorphic ventricular tachycardia caused by arsenic trioxide therapy for acute promyelocytic leukaemia.|pdf=|usr=}}
| |
| − | {{tp|p=6471847|t=1984. EKG of the month. Torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=9140328|t=1997. Recurrent ventricular tachyarrhythmias associated with QT prolongation following hydrofluoric acid burns.|pdf=|usr=}}
| |
| − | {{tp|p=7837314|t=1995. Magnesium sulfate in the treatment of ventricular arrhythmias due to digoxin toxicity.|pdf=|usr=}}
| |
| − | {{tp|p=8230644|t=1993. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.|pdf=|usr=}}
| |
| − | {{tp|p=1749066|t=1991. Treatment of torsade de pointes with intravenous magnesium in idiopathic long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=8973383|t=1996. Effects of antiarrhythmic agents and Mg2+ on aconitine-induced arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=9057687|t=1996. Anticholinergic overdose induced torsade de pointes successfully treated with verapamil.|pdf=|usr=}}
| |
| − | {{tp|p=2724543|t=1989. Sheehan's syndrome with hypomagnesemia and polymorphous ventricular tachycardia.|pdf=|usr=}}
| |
| − | {{tp|p=7230515|t=1981. Etiology of QT prolongation and T wave changes in chronic alcoholism.|pdf=|usr=}}
| |
| − | {{tp|p=28294893|t=2016. [On Synergism of Potassium and Magnesium in Maintenance of Myocardial Function].|pdf=|usr=}}
| |
| − | {{tp|p=17495849|t=2007. [The efficacy and safety of nibentan for pharmacological cardioversion in patients with persistent atrial fibrillation and flutter: the role of dose limitation and magnesium sulfate administration].|pdf=|usr=}}
| |
| − | {{tp|p=1479796|t=1992. Atypische Form eines Long-QT-Syndroms--ein Fallbericht.|pdf=|usr=}}
| |
| − | {{tp|p=8256055|t=1993. [A case of life-threatening ventricular arrhythmias probably due to psychotropic drugs].|pdf=|usr=}}
| |
| − | {{tp|p=1325665|t=1992. [Antiarrhythmic effects of magnesium on single ventricular myocytes].|pdf=|usr=}}
| |
| − | {{tp|p=1348867|t=1992. [A case of congenital long QT syndrome associated with T wave alternans].|pdf=|usr=}}
| |
| − | {{tp|p=2047605|t=1991. [Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].|pdf=|usr=}}
| |
| − | {{tp|p=3532248|t=1986. [Clinical significance of QT interval].|pdf=|usr=}}
| |
| − | {{tp|p=8105332|t=1993. Does antiarrhythmic magnesium therapy enhance malarial infection?|pdf=|usr=}}
| |
| − | {{tp|p=31298598|t=2019. QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia.|pdf=|usr=}}
| |
| − | {{tp|p=7999530|t=1994. Antiarrhythmic effect of parenteral magnesium on ventricular tachycardia associated with long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=7999528|t=1994. Should magnesium therapy be considered for the treatment of coronary heart disease? I. A critical appraisal of current facts and hypotheses.|pdf=|usr=}}
| |
| − | {{tp|p=1296762|t=1992. New data on the antiarrhythmic value of parenteral magnesium treatment: magnesium and ventricular arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=2693848|t=1989. Magnesium therapy of cardiac arrhythmias in critical-care medicine.|pdf=|usr=}}
| |
| − | {{tp|p=3523053|t=1986. Magnesium and cardiac arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=15301336|t=2004. Acquired long QT syndrome and monomorphic ventricular tachycardia after alternative treatment with cesium chloride for brain cancer.|pdf=|usr=}}
| |
| − | {{tp|p=8189766|t=1994. Torsades de pointes ventricular tachycardia associated with overdose of astemizole.|pdf=|usr=}}
| |
| − | {{tp|p=28828702|t=2017. Vergiftungen mit psychotropen Substanzen.|pdf=|usr=}}
| |
| − | {{tp|p=27906148|t=2016. In brief: PPIs and Torsades de Pointes.|pdf=|usr=}}
| |
| − | {{tp|p=22970526|t=2012. Magnesium-Mangel und Arzneimittel.|pdf=|usr=}}
| |
| − | {{tp|p=15974204|t=2005. Bradycardia-associated torsade de pointes and the long-QT syndromes: a case report and review of the literature.|pdf=|usr=}}
| |
| − | {{tp|p=1407620|t=1992. Torsione di punta iatrogena indotta da tioridazina.|pdf=|usr=}}
| |
| − | {{tp|p=10783591|t=1999. Cisapride e rischio di complicanze cardiache.|pdf=|usr=}}
| |
| − | {{tp|p=11349326|t=2001. Herzrhythmusstorungen. Torsade de pointes durch Hypokaliamie.|pdf=|usr=}}
| |
| − | {{tp|p=8587608|t=1996. The inward rectification mechanism of the HERG cardiac potassium channel.|pdf=|usr=}}
| |
| − | {{tp|p=18648775|t=2008. An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.|pdf=|usr=}}
| |
| − | {{tp|p=17093009|t=2007. Sudden cardiac death in nephrology: focus on acquired long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=12053061|t=2002. QT dispersion in renal transplant recipients.|pdf=|usr=}}
| |
| − | {{tp|p=9578069|t=1998. Effect of hemodialysis on the dispersion of the QTc interval.|pdf=|usr=}}
| |
| − | {{tp|p=17003569|t=2006. Blockade of renin-angiotensin system reduces QT dispersion and improves intracellular Ca/Mg status in hemodialysis patients.|pdf=|usr=}}
| |
| − | {{tp|p=16166802|t=2006. Calcitriol regresses cardiac hypertrophy and QT dispersion in secondary hyperparathyroidism on hemodialysis.|pdf=|usr=}}
| |
| − | {{tp|p=29923812|t=2018. The Identification of Torsades de Pointes via CEEG: A Case Report on a Patient with Physiologically Provoked Nonepileptic Events.|pdf=|usr=}}
| |
| − | {{tp|p=23452578|t=2013. QTc prolongation after brain surgery.|pdf=|usr=}}
| |
| − | {{tp|p=7993632|t=1994. Kir2.1 inward rectifier K+ channels are regulated independently by protein kinases and ATP hydrolysis.|pdf=|usr=}}
| |
| − | {{tp|p=18652879|t=2008. Elementary properties of Kir2.1, a strong inwardly rectifying K(+) channel expressed by pigeon vestibular type II hair cells.|pdf=|usr=}}
| |
| − | {{tp|p=18074575|t=2007. [Drug-induced long QT syndrome].|pdf=|usr=}}
| |
| − | {{tp|p=16001778|t=2005. [Long QT syndrome].|pdf=|usr=}}
| |
| − | {{tp|p=12136628|t=2002. [Drug-induced arrhythmias].|pdf=|usr=}}
| |
| − | {{tp|p=8810801|t=1996. [Drug-induced arrhythmias].|pdf=|usr=}}
| |
| − | {{tp|p=1685194|t=1991. [Torsade de pointes].|pdf=|usr=}}
| |
| − | {{tp|p=7476792|t=1994. Torsade de pointes and elevated magnesium and calcium requirements associated with intravenous pentamidine.|pdf=|usr=}}
| |
| − | {{tp|p=32086826|t=2020. Chemical cardioversion of atrial flutter and fibrillation in the pediatric population with Ibutilide.|pdf=|usr=}}
| |
| − | {{tp|p=27628760|t=2016. Provider Response to QTc Prolongation on Standard 12-Lead EKG: Do We Notice or Do We Care?|pdf=|usr=}}
| |
| − | {{tp|p=21039642|t=2013. Pregnancy and short-coupled torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=17976094|t=2007. Intravenous magnesium sulfate enhances the ability of intravenous ibutilide to successfully convert atrial fibrillation or flutter.|pdf=|usr=}}
| |
| − | {{tp|p=16105013|t=2005. Effects of intravenous magnesium in a prolonged QT interval model of polymorphic ventricular tachycardia focus on transmural ventricular repolarization.|pdf=|usr=}}
| |
| − | {{tp|p=9604253|t=1998. Sotalol associated torsades de pointes tachycardia in a 15-month-old child: successful therapy with magnesium aspartate.|pdf=|usr=}}
| |
| − | {{tp|p=7681173|t=1993. Early afterdepolarization in a patient with complete atrioventricular block and torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=7690949|t=1993. Torsades de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=1376904|t=1992. TU alternans, long QTU, and torsade de pointes: clinical and experimental observations.|pdf=|usr=}}
| |
| − | {{tp|p=1721131|t=1991. Association of humps on monophasic action potentials and ST-T alternans in a patient with Romano-Ward syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=1695751|t=1990. Magnesium therapy in ventricular arrhythmias.|pdf=|usr=}}
| |
| − | {{tp|p=25701242|t=2015. Hypomagnesemic down-regulation of L-type Ca(2+) channel in cardiomyocyte as an arrhythmogenic substrate in rats.|pdf=|usr=}}
| |
| − | {{tp|p=11922507|t=2002. Studies of magnesium in congenital long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=7784240|t=1995. Effective use of magnesium for acquired torsade de pointes in a 4-month-old infant.|pdf=|usr=}}
| |
| − | {{tp|p=17251875|t=2007. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury.|pdf=|usr=}}
| |
| − | {{tp|p=24694881|t=2014. Acquired long QT syndrome: a focus for the general pediatrician.|pdf=|usr=}}
| |
| − | {{tp|p=15094576|t=2004. Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol.|pdf=|usr=}}
| |
| − | {{tp|p=8247942|t=1993. Torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=8488140|t=1993. Torsade de pointes associated with Astemizole overdose treated with magnesium sulfate.|pdf=|usr=}}
| |
| − | {{tp|p=16635167|t=2006. Successful uses of magnesium sulfate for torsades de pointes in children with long QT syndrome.|pdf=|usr=}}
| |
| − | {{tp|p=23760993|t=2013. QT and JT dispersion and cardiac performance in children with neonatal Bartter syndrome: a pilot study.|pdf=|usr=}}
| |
| − | {{tp|p=12837909|t=2003. Iatrogenic acute hypermagnesemia after total parenteral nutrition infusion mimicking septic shock syndrome: two case reports.|pdf=|usr=}}
| |
| − | {{tp|p=19002489|t=2009. Human Kir2.1 channel carries a transient outward potassium current with inward rectification.|pdf=|usr=}}
| |
| − | {{tp|p=9019734|t=1996. Heterooligomeric assembly of inward-rectifier K+ channels from subunits of different subfamilies: Kir2.1 (IRK1) and Kir4.1 (BIR10).|pdf=|usr=}}
| |
| − | {{tp|p=15918160|t=2005. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system.|pdf=|usr=}}
| |
| − | {{tp|p=12076305|t=2002. Drug-induced ventricular tachyarrhythmia in isolated rabbit hearts with atrioventricular block.|pdf=|usr=}}
| |
| − | {{tp|p=29380488|t=2018. Validation and Clinical Utility of the hERG IC50:Cmax Ratio to Determine the Risk of Drug-Induced Torsades de Pointes: A Meta-Analysis.|pdf=|usr=}}
| |
| − | {{tp|p=29882591|t=2018. Predictive Analytics for Identification of Patients at Risk for QT Interval Prolongation: A Systematic Review.|pdf=|usr=}}
| |
| − | {{tp|p=17316157|t=2007. Management of dofetilide overdose in a patient with known cocaine abuse.|pdf=|usr=}}
| |
| − | {{tp|p=8643894|t=1996. Der klinisch-pharmakologische Fall (2).Bradykardie und ventrikulare Tachykardia vom Typ Torsade de pointes als Nebenwirkung von Vasopressin: drei Fallberichte.|pdf=|usr=}}
| |
| − | {{tp|p=7754271|t=1995. Magnesium in der Kardiologie.|pdf=|usr=}}
| |
| − | {{tp|p=3157959|t=1985. Torsades de pointes chez l'alcoolique.|pdf=|usr=}}
| |
| − | {{tp|p=3157953|t=1985. Traitement des torsades de pointes par le sulfate de magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=12893979|t=2003. Why is the QT interval measurement so critical when evaluating an ECG rhythm?|pdf=|usr=}}
| |
| − | {{tp|p=16951992|t=2006. Effects of metal-binding properties of human Kv channel-interacting proteins on their molecular structure and binding with Kv4.2 channel.|pdf=|usr=}}
| |
| − |
| |
| − | {{tp|p=19508229|t=2009. Functional roles of EF-hands in human potassium channel-interacting protein 2.2.|pdf=|usr=}}
| |
| − | {{tp|p=16901607|t=2006. Hypomagnesaemia causing QT interval prolongation and torsade de pointes in an alcoholic patient.|pdf=|usr=}}
| |
| − | {{tp|p=2326522|t=1990. Arritmia cardiaca grave secundaria a deplecion de magnesio. Torsade de pointe.|pdf=|usr=}}
| |
| − | {{tp|p=7209092|t=1980. Alternancia electrica de la onda T y "torsades de pointes".|pdf=|usr=}}
| |
| − | {{tp|p=23167136|t=2012. Le magnesium, applications en soins intensifs et en anesthesiologie.|pdf=|usr=}}
| |
| − | {{tp|p=31373450|t=2019. Torsade de pointe sur interaction medicamenteuse entre sotalol et ciprofloxacine.|pdf=|usr=}}
| |
| − | {{tp|p=28692217|t=2016. Le magnesium dans la pratique clinique quotidienne.|pdf=|usr=}}
| |
| − | {{tp|p=24024425|t=2013. Le QT long acquis.|pdf=|usr=}}
| |
| − | {{tp|p=2631832|t=1989. Eficacia terapeutica do sulfato de magnesio por via intravenosa em taquidisritmias. A proposito de quatro casos clinicos.|pdf=|usr=}}
| |
| − | {{tp|p=8497770|t=1993. Gefahrliche Rhythmusstorungen.|pdf=|usr=}}
| |
| − | {{tp|p=8421775|t=1993. Das "cardiac ballet" mit und ohne Amiodaron.|pdf=|usr=}}
| |
| − | {{tp|p=1699270|t=1990. Hemiparese und Torsade de pointes unter niedrigdosierter Therapie mit Sotalol.|pdf=|usr=}}
| |
| − | {{tp|p=3070741|t=1988. Magnesium in der Kardiologie. Grundlagen und mogliche Indikationen.|pdf=|usr=}}
| |
| − | {{tp|p=30620510|t=2016. [Long QT Syndrome Induced by Antidepressants].|pdf=|usr=}}
| |
| − | {{tp|p=9459289|t=1998. Hypomagnesemia: renal magnesium handling.|pdf=|usr=}}
| |
| − | {{tp|p=10709414|t=1999. Electrocardiographic case: a middle aged, seriously ill woman with an unusual ECG and wide complex tachycardia.|pdf=|usr=}}
| |
| − | {{tp|p=8266190|t=1993. Torsade de pointes and sudden death associated with diabetic autonomic diarrhoea--a case report.|pdf=|usr=}}
| |
| − | {{tp|p=11811859|t=2001. Magnesium: its proven and potential clinical significance.|pdf=|usr=}}
| |
| − | {{tp|p=10586828|t=1999. Magnesium for the next millennium.|pdf=|usr=}}
| |
| − | {{tp|p=9042182|t=1997. Hyperphosphatemia associated with phosphorus-containing laxatives in a patient with chronic renal insufficiency.|pdf=|usr=}}
| |
| − | {{tp|p=14963284|t=2004. Electrocardiographic abnormalities and serum magnesium in patients with subarachnoid hemorrhage.|pdf=|usr=}}
| |
| − | {{tp|p=19418112|t=2009. QT interval prolongation among patients treated with angiogenesis inhibitors.|pdf=|usr=}}
| |
| − | {{tp|p=8091345|t=1993. Pathologie cardiovasculaire et magnesium.|pdf=|usr=}}
| |
| − | {{tp|p=2094063|t=1990. Effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=18067651|t=2007. Assessment of corrected QT interval in sickle-cell disease patients who undergo erythroapheresis.|pdf=|usr=}}
| |
| − | {{tp|p=20620555|t=2010. Torsades de pointes triggered by severe diastolic hypotension with low hematocrit in the neohepatic stage of liver transplantation: a case report.|pdf=|usr=}}
| |
| − | {{tp|p=10770105|t=1999. Torsade de pointes associated with encephalitis.|pdf=|usr=}}
| |
| − | {{tp|p=8701528|t=1996. Torsade de pointes-takykardi ved sotalolbehandling af en normokaliaemisk patient.|pdf=|usr=}}
| |
| − | {{tp|p=15287289|t=2004. Eclampsia and abnormal QTc.|pdf=|usr=}}
| |
| − | {{tp|p=18365152|t=2008. Medikamentos induzierte Verlangerung des QT-Intervalls.|pdf=|usr=}}
| |
| − | {{tp|p=11105328|t=2000. Der Stellenwert von Magnesium bei Herzrhythmusstorungen.|pdf=|usr=}}
| |
| − | {{tp|p=27878411|t=2018. Riskante Gabe von QT-Intervall-verlangernden Wirkstoffen bei alteren Patienten mit arzneimittelinduzierter Torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=9064959|t=1996. Magnesium: Aktuelle Studien--kritische Wertung--Konsequenzen.|pdf=|usr=}}
| |
| − | {{tp|p=9064958|t=1996. Magnesium als antiarrhythmisches Therapieprinzip bei supraventrikularen und ventrikularen Herzrhythmusstorungen.|pdf=|usr=}}
| |
| − | {{tp|p=7502575|t=1995. Sotalol-induzierte Torsade-de-Pointes-Tachykardien bei einem 15 Monate alten Kleinkind.|pdf=|usr=}}
| |
| − | {{tp|p=7863684|t=1994. Die Bedeutung von Magnesium in der Intensivmedizin.|pdf=|usr=}}
| |
| − | {{tp|p=8147050|t=1993. Torsade de pointes.|pdf=|usr=}}
| |
| − | {{tp|p=29926671|t=2018. [Anti-arrhythmic effects of taurine-magnesium coordination compound on torsades de pointes].|pdf=|usr=}}
| |
| − | {{tp|p=8404313|t=1993. [Classification and treatment of torsades de pointes (TdP): a report of 11 cases].|pdf=|usr=}}
| |
| − | {{tp|p=21624302|t=2011. [Clinical characteristics and outcome of 32 patients with long-QT syndrome accompanied with torsade de pointes].|pdf=|usr=}}
| |
| − | {{tp|p=21624301|t=2011. [Clinical characteristics of 52 patients with torsade de points associated with acquired QT prolongation].|pdf=|usr=}}
| |
| − | {{tp|p=17386161|t=2007. [The effects of calmodulin kinase II inhibitor on ventricular arrhythmias in rabbits with cardiac hypertrophy].|pdf=|usr=}}
| |
| − | {{tp|p=15932674|t=2005. [Calmodulin antagonist inhibits torsade de pointes induced by d-sotalol in an isolated rabbit heart model].|pdf=|usr=}}
| |
| − | {{tp|p=8854446|t=1995. Acquired long QT syndrome in a child undergoing craniotomy: a case report.|pdf=|usr=}}
| |
